PDx BLOG
Post categorized under: PDx Blog
PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for labs. Our team has curated content around Cannabis, Food Safety, and Life Sciences to drive the future of safe.
- PathogenDx Is Headed To AAFP: Introducing SeroXMore »
This year, PathogenDx is proud to sponsor the Arkansas Association of Food Protection (AAFP) Conference, and introduce the Future of Safe in Poultry with its SeroX assay. Developed on our highly multiplexed and patented D3 Array™, PathogenDx now delivers ultra-rapid Salmonella detection and Serotyping in a single well reaction, at a fraction of the ...
- Introducing D3 Array™-UTI to the Executive War CollegeMore »
Today, a wide range of urinary tract conditions are considered either complex or recurrent, creating the need for more complete and rapid insight.
Introducing PathogenDx D3 Array™-UTI to Executive War College. This is a fast multiplexed testing solution for urinary pathogen detection run simultaneously with antibiotic resistance gene markers. This ...
- DOWNLOAD WHITEPAPER – A New & Novel Approach: UTI Detection + Antibiotic Resistance in a Rapid Affordable TestMore »
Treatment of Urinary Tract Infections is time-consuming, taking anywhere from 2-5 days if antibiotic resistance genes are also tested. When misdiagnosed and further treatment becomes necessary, costs become unmanageable. PathogenDx D3 Array™-UTI is a fast multiplexed platform for urinary pathogen detection ...
- SNAPSHOT: WHY NOVEL MULTIPLEXED MOLECULAR DIAGNOSTICS MATTERS?More »
Today, across clinical testing demands, there are instances where diagnostic pathogen testing conducted through well-known qPCR (quantitative polymerase chain reaction) and NGS (next-generation genomic sequencing) can ...
- INNOVATION SUPPORTING WOMEN’S HEALTH—D3 ARRAY™-UTI.More »
It’s important to women and the doctors that treat them. It’s important to labs. It’s exciting for all of us at PathogenDx. As 2024 ramps up, we are proud to announce that our latest application of PathogenDx D3 Dynamic Dimensional Detection platform (visit our science page here to learn about ...
- Salmonella Serotype DetectionMore »
The D3 Array is expanding into the poultry industry with salmonella serotyope detection.
- Lab Manager Article: The promise of the PathogenDx D3 Array™More »
The D3 Array is expanding into the clinical and agricultural spaces, providing low-cost multiplex testing.
- Meet Your State’s Cannabis Testing RequirementsMore »
In this innovation update, Senior Scientist Austin Rueda introduces QuantX Bacterial from PathogenDx. QuantX Bacterial delivers the flexibility that labs need to conform to each state’s specific cannabis testing rules and regulations, quantify four broad class indicators, and deliver species-specific detection all within a single test.
- Changing the Molecular Testing Playing Field: PathogenDx’s D3 ArrayMore »
By Susan Evans
What if you could create a testing environment that enhances the ability for a clinical sample, such as a bacterium responsible for an infection, to find and bind to a molecular detection probe? If you could, you would have the potential to significantly increase the testing speed, improving patient outcome and care, while also increasing the accuracy and sensitivity of the laboratory test. The future of molecular testing.
- Bacterial Quantification: A Hierarchical Approach from PathogenDxMore »
By Austin Rueda
Cannabis spp. is host to many bacterial pathogens of immediate concern to public health and safety. These bacterial pathogens can be broken down into categories of specific interest such as Total Aerobic Bacteria, Bile Tolerant Gram-Negative Bacteria, Total Enterobacteriaceae, and Total Coliform Bacteria.
Recent Comments